Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development.

Portugal LR, Fernandes LR, Alvarez-Leite JI.

Expert Rev Anti Infect Ther. 2009 Sep;7(7):807-19. doi: 10.1586/eri.09.60. Review.

PMID:
19735223
2.

Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii.

Aliberti J.

Nat Rev Immunol. 2005 Feb;5(2):162-70. Review. Erratum in: Nat Rev Immunol. 2005 Jun;5(6):512.

PMID:
15662369
3.

Influence of low-density lipoprotein (LDL) receptor on lipid composition, inflammation and parasitism during Toxoplasma gondii infection.

Portugal LR, Fernandes LR, Pietra Pedroso VS, Santiago HC, Gazzinelli RT, Alvarez-Leite JI.

Microbes Infect. 2008 Mar;10(3):276-84. doi: 10.1016/j.micinf.2007.12.001. Epub 2007 Dec 8.

PMID:
18316222
4.

Turning it on and off: regulation of dendritic cell function in Toxoplasma gondii infection.

Aliberti J, Jankovic D, Sher A.

Immunol Rev. 2004 Oct;201:26-34. Review.

PMID:
15361230
5.

Toxoplasma gondii: host-parasite interaction and behavior manipulation.

da Silva RC, Langoni H.

Parasitol Res. 2009 Oct;105(4):893-8. doi: 10.1007/s00436-009-1526-6. Epub 2009 Jun 23. Review.

PMID:
19548003
6.

Toxoplasma gondii and subversion of the immune system.

Buzoni-Gatel D, Werts C.

Trends Parasitol. 2006 Oct;22(10):448-52. Epub 2006 Aug 9. Review.

PMID:
16904378
7.

Toxoplasma gondii effectors are master regulators of the inflammatory response.

Melo MB, Jensen KD, Saeij JP.

Trends Parasitol. 2011 Nov;27(11):487-95. doi: 10.1016/j.pt.2011.08.001. Epub 2011 Sep 3. Review.

8.

[Invasiveness and intracellular parasitism of Toxoplasma gondii].

Długońska H.

Wiad Parazytol. 2005;51(3):213-7. Review. Polish.

PMID:
16913525
9.

Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii.

Dzierszinski FS, Hunter CA.

Parasite Immunol. 2008 Apr;30(4):235-44. doi: 10.1111/j.1365-3024.2007.01016.x. Epub 2008 Jan 8. Review.

10.

[Toxoplasma gondii--intracellular parasite].

Długońska H.

Wiad Parazytol. 2002;48(1):23-8. Review. Polish.

PMID:
16883700
12.

Neuropsychiatric disease and Toxoplasma gondii infection.

Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW.

Neuroimmunomodulation. 2009;16(2):122-33. doi: 10.1159/000180267. Epub 2009 Feb 11. Review.

PMID:
19212132
13.

[Cell-host-parasite interactions: biodiversity, pathogenesis, environment].

Villena I, Aubert D, Pinon JM.

Ann Pharm Fr. 2006 Mar;64(2):115-20. Review. French.

PMID:
16568012
14.
15.

Deploying parasite profilin on a mission of invasion and danger.

Denkers EY, Striepen B.

Cell Host Microbe. 2008 Feb 14;3(2):61-3. doi: 10.1016/j.chom.2008.01.003. Review.

16.

Genetic analysis of host resistance to intracellular pathogens: lessons from studies of Toxoplasma gondii infection.

Yap GS, Shaw MH, Ling Y, Sher A.

Microbes Infect. 2006 Apr;8(4):1174-8. Epub 2006 Jan 18. Review.

PMID:
16513380
17.

Impact of lipoxin-mediated regulation on immune response to infectious disease.

Machado FS, Aliberti J.

Immunol Res. 2006;35(3):209-18. Review.

PMID:
17172647
18.

Pathogenesis of toxoplasmosis.

Bhopale GM.

Comp Immunol Microbiol Infect Dis. 2003 Jul;26(4):213-22. Review.

PMID:
12676122
19.

Anti-inflammatory pathways as a host evasion mechanism for pathogens.

Aliberti J, Bafica A.

Prostaglandins Leukot Essent Fatty Acids. 2005 Sep-Oct;73(3-4):283-8. Review.

PMID:
15982863
20.

Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.

el Kouni MH.

Curr Pharm Des. 2007;13(6):581-97. Review.

PMID:
17346176

Supplemental Content

Support Center